Cargando…
Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands
We present the type-distribution of high-risk human papillomavirus (HPV) types in women with normal cytology (n=1467), adenocarcinoma in situ (ACIS) (n=61), adenocarcinoma (n=70), and squamous cell carcinoma (SCC) (n=83). Cervical adenocarcinoma and ACIS were significantly more frequently associated...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361088/ https://www.ncbi.nlm.nih.gov/pubmed/16404371 http://dx.doi.org/10.1038/sj.bjc.6602915 |
_version_ | 1782153138390695936 |
---|---|
author | Bulk, S Berkhof, J Bulkmans, N W J Zielinski, G D Rozendaal, L van Kemenade, F J Snijders, P J F Meijer, C J L M |
author_facet | Bulk, S Berkhof, J Bulkmans, N W J Zielinski, G D Rozendaal, L van Kemenade, F J Snijders, P J F Meijer, C J L M |
author_sort | Bulk, S |
collection | PubMed |
description | We present the type-distribution of high-risk human papillomavirus (HPV) types in women with normal cytology (n=1467), adenocarcinoma in situ (ACIS) (n=61), adenocarcinoma (n=70), and squamous cell carcinoma (SCC) (n=83). Cervical adenocarcinoma and ACIS were significantly more frequently associated with HPV18 (OR(MH) 15.0; 95% CI 8.6–26.1 and 21.8; 95% CI 11.9–39.8, respectively) than normal cytology. Human papillomavirus16 was only associated with adenocarcinoma and ACIS after exclusion of HPV18-positive cases (OR(MH) 6.6; 95% CI 2.8–16.0 and 9.4; 95% CI 2.8–31.2, respectively). For SCC, HPV16 prevalence was elevated (OR(MH) 7.0; 95% CI 3.9–12.4) compared to cases with normal cytology, and HPV18 prevalence was only increased after exclusion of HPV16-positive cases (OR(MH) 4.3; 95% CI 1.6–11.6). These results suggest that HPV18 is mainly a risk factor for the development of adenocarcinoma whereas HPV16 is associated with both SCC and adenocarcinoma. |
format | Text |
id | pubmed-2361088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23610882009-09-10 Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands Bulk, S Berkhof, J Bulkmans, N W J Zielinski, G D Rozendaal, L van Kemenade, F J Snijders, P J F Meijer, C J L M Br J Cancer Epidemiology We present the type-distribution of high-risk human papillomavirus (HPV) types in women with normal cytology (n=1467), adenocarcinoma in situ (ACIS) (n=61), adenocarcinoma (n=70), and squamous cell carcinoma (SCC) (n=83). Cervical adenocarcinoma and ACIS were significantly more frequently associated with HPV18 (OR(MH) 15.0; 95% CI 8.6–26.1 and 21.8; 95% CI 11.9–39.8, respectively) than normal cytology. Human papillomavirus16 was only associated with adenocarcinoma and ACIS after exclusion of HPV18-positive cases (OR(MH) 6.6; 95% CI 2.8–16.0 and 9.4; 95% CI 2.8–31.2, respectively). For SCC, HPV16 prevalence was elevated (OR(MH) 7.0; 95% CI 3.9–12.4) compared to cases with normal cytology, and HPV18 prevalence was only increased after exclusion of HPV16-positive cases (OR(MH) 4.3; 95% CI 1.6–11.6). These results suggest that HPV18 is mainly a risk factor for the development of adenocarcinoma whereas HPV16 is associated with both SCC and adenocarcinoma. Nature Publishing Group 2006-01-16 2005-12-13 /pmc/articles/PMC2361088/ /pubmed/16404371 http://dx.doi.org/10.1038/sj.bjc.6602915 Text en Copyright © 2006 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Epidemiology Bulk, S Berkhof, J Bulkmans, N W J Zielinski, G D Rozendaal, L van Kemenade, F J Snijders, P J F Meijer, C J L M Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands |
title | Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands |
title_full | Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands |
title_fullStr | Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands |
title_full_unstemmed | Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands |
title_short | Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands |
title_sort | preferential risk of hpv16 for squamous cell carcinoma and of hpv18 for adenocarcinoma of the cervix compared to women with normal cytology in the netherlands |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361088/ https://www.ncbi.nlm.nih.gov/pubmed/16404371 http://dx.doi.org/10.1038/sj.bjc.6602915 |
work_keys_str_mv | AT bulks preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands AT berkhofj preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands AT bulkmansnwj preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands AT zielinskigd preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands AT rozendaall preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands AT vankemenadefj preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands AT snijderspjf preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands AT meijercjlm preferentialriskofhpv16forsquamouscellcarcinomaandofhpv18foradenocarcinomaofthecervixcomparedtowomenwithnormalcytologyinthenetherlands |